DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Dynavax Technologies Corporation (DVAX)
« Back to company indexDVAX Chatter Timeline
Stock Ticker for DVAX
Most Active Tweeters for DVAX
| User | Tweets |
|---|---|
| @MaisaCorp | 5 |
| @AmericanBanking | 4 |
| @TopStockAlerts1 | 4 |
| @bulletin_en | 4 |
| @1MinuteStock | 4 |
Recent Tweets for DVAX
 |
@dbuello All out of $DVAX, Add it to a long list of success followed quickly by failure. Quickly learning that while gaining… https://t.co/2dcVLOvcut May 23rd 2019, 8:05pm |
 |
@1MinuteStock Btw, Estimated #Earnings Per Share for $DVAX is $-0.17 it's -2.67% of the current price https://t.co/O6sAzMid9J May 23rd 2019, 7:05pm |
 |
@Bigapple2la $DVAX finally admits SD-101 melanoma data was a bust, kind of. May 23rd 2019, 7:05pm |
 |
@Sanctuary_Bio In light of $DVAX update, remember this Gl if you are in this name https://t.co/D2w5q1VHEE May 23rd 2019, 7:05pm |
 |
@Briefingcom $DVAX: Dynavax announces restructuring; will explore strategic alternatives for immuno-oncology programs; CEO to... https://t.co/aTIl25wjFh May 23rd 2019, 6:05pm |
 |
@StockMatusow @TheRealANC However, make your fundamental case, WHY will the $DVAX ship turn around specifically? Not what you hop… https://t.co/A8qbt04mV0 May 23rd 2019, 6:05pm |
 |
@MarketChmln $DVAX #DynavaxTechnologies declines in after hours trading. See the latest news. https://t.co/PIFUgBpFa0 https://t.co/wy3jef7UkG May 23rd 2019, 6:05pm |
 |
@MarketCurrents $DVAX - Dynavax to focus on vaccines; CEO retires; shares -7.9% https://t.co/IyMzGUj2Nr May 23rd 2019, 6:05pm |
 |
@dhovekamp42 RT @zbiotech: $DVAX restructuring, cuts 37% of workforce CEO to 'retire' exploring options for SD-101, focus on vaccine May 23rd 2019, 6:05pm |
 |
@The_Squibb With the overpaid, non-performing CEO gone, along with the oncology money pit, this just as much positive as it is negative. $DVAX May 23rd 2019, 6:05pm |
|
@StockMatusow @ANACONDAFINANC1 @TheBestCybers The best-laid plans of mice and men often go awry :) $DVAX May 23rd 2019, 5:05pm |
 |
@Allstocknews $DVAX New Form DEFA14A for Dynavax Technologies Corporation From our Stock News Alerts App May 23rd 2019, 5:05pm |
 |
@RSIDayTrader $DVAX bk soon enough May 23rd 2019, 5:05pm |
 |
@CHItraders $DVAX Dynavax announces layoffs, CEO retirement - MarketWatch https://t.co/90RayRl63t) May 23rd 2019, 5:05pm |
 |
@bs2537 $DVAX decision to divest SD-101, bad news for similar private companies likle Checkmate Pharmaceuticals. (no positi… https://t.co/JeMTQMQB7Y May 23rd 2019, 5:05pm |
 |
@MaisaCorp $DVAX summary: Company will explore strategic alternatives for its immuno-oncology programs Eddie Gray, CEO,… https://t.co/iqQvDXrYHD May 23rd 2019, 5:05pm |
|
@MaisaCorp $DVAX resumes May 23rd 2019, 5:05pm |
|
@MaisaCorp $DVAX As of March 31, 2019, the company reported cash, cash equivalents and marketable securities totaling $183.2 million. May 23rd 2019, 5:05pm |
|
@MaisaCorp $DVAX The company’s board of directors has created an interim Office of the President and has appointed David Nov… https://t.co/NVU2eYO64d May 23rd 2019, 5:05pm |
|
@MaisaCorp $DVAX As a result, the board and management have made the difficult decision to reduce our workforce. We want to… https://t.co/T7A77AD8ac May 23rd 2019, 5:05pm |
 |
@BioRunUp RT @TraderTexMex: $DVAX Dynavax Announces Strategic Restructuring to Focus on its Vaccine Business May 23rd 2019, 5:05pm |
 |
@gcbioinv $DVAX restructuring to focus on Heplisav, exploring strategics for immunooncology assets May 23rd 2019, 5:05pm |
 |
@funstocks1 @zerosum24 $DVAX Wonder anyone will be interested in #SD101 aka #TLR9 agonist that lacks single agent activity yet… https://t.co/V57vWnUhxn May 23rd 2019, 5:05pm |
 |
@PredatorDiaries @TraderTexMex After a job well done. Sorry Eddie, we met when we were both at SmithKline, but $DVAX was a different gig May 23rd 2019, 4:05pm |
 |
@zerosum24 $DVAX another biotech disaster May 23rd 2019, 4:05pm |
|
@zerosum24 $DVAX - UPDATE: Dynavax Says Will Reduce Co. Workforce, Operations To Focus Resources On HEPLISAV-B Commercialization May 23rd 2019, 4:05pm |
|
@zerosum24 $DVAX - Dynavax To Restructure to Prioritize Its Vaccine Unit By Focusing Co.'s First Commercial Product HEPLISAV-B May 23rd 2019, 4:05pm |
|
@zerosum24 $DVAX Dynavax Reports Co. Will Explore Strategic Alternatives For Its Immuno-Oncology Programs.. May 23rd 2019, 4:05pm |
 |
@Drchik23 $DVAX Dynavax Announced Strategic Restructuring to Focus on its Vaccine Business. CEO retiring. Halted until 5:15. May 23rd 2019, 4:05pm |
 |
@StockTexts $DVAX Dynavax Announces Strategic Restructuring to Focus on its Vaccine Business Nasdaq:DVAX https://t.co/b64JfomZQd May 23rd 2019, 4:05pm |
 |
@LargeVoidBot $DVAX Will resume 17:15:00. News and Resumption Times. (Halted: 16:42:49) May 23rd 2019, 4:05pm |
|
@Allstocknews $DVAX Dynavax Announces Strategic Restructuring to Focus on its Vaccine Business From our Stock News Alerts App May 23rd 2019, 4:05pm |
|
@StockMatusow Congrats $DVAX, you just assured your stock is going the $SGYP route. = ZERO #Biotech - yet another mismanaged TURD… https://t.co/ES6xuKIrBG May 23rd 2019, 4:05pm |
 |
@zbiotech $DVAX restructuring, cuts 37% of workforce CEO to 'retire' exploring options for SD-101, focus on vaccine May 23rd 2019, 4:05pm |
|
@LargeVoidBot $DVAX Halt - News Released. Halt time: 16:42:49. May 23rd 2019, 4:05pm |
 |
@TraderTexMex $DVAX CEO retiring May 23rd 2019, 4:05pm |
|
@TraderTexMex $DVAX Dynavax Announces Strategic Restructuring to Focus on its Vaccine Business May 23rd 2019, 4:05pm |
 |
@SudhanvaRaj RT @RTFilingsStocks: $DVAX halted News Pending May 23rd 2019, 4:05pm |
 |
@StockHaltBot HALTED: $DVAX Date: 2019-05-23 Time: 16:42:49 Code: T1 May 23rd 2019, 4:05pm |
 |
@RTFilingsStocks $DVAX halted News Pending May 23rd 2019, 4:05pm |
|
@LargeVoidBot $DVAX Halt - News Pending. Halt time: 16:42:49. May 23rd 2019, 4:05pm |
 |
@Tickeron $DVAX Dynavax Technologies (DVAX, $6.55) was this quarter's top loser, falling -40% https://t.co/pzn3CL8Zy0 May 22nd 2019, 10:05pm |
|
@Tickeron $DVAX Dynavax Technologies (DVAX, $6.55) was the market's top winner yesterday, jumping +8.62% https://t.co/LGIL0jRlWo May 22nd 2019, 12:05pm |
|
@Tickeron $DVAX Dynavax Technologies (DVAX, $6.03) was this quarter's top loser, falling -45% https://t.co/BMMVWB5eFd May 21st 2019, 10:05pm |
 |
@WalterBriBri @scientwest Or does that decrease the percentage of success for SD-101? I can see it both ways. I'd rather $DVAX be… https://t.co/Spp7FgpOEU May 21st 2019, 6:05pm |
 |
@SwingTradeBot Recent $DVAX technical alerts: New 52 Week Low plus 4 more alerts... https://t.co/f3bAAYyT8w May 21st 2019, 10:05am |
 |
@biotechw2019 $DVAX $6 gap now fully filled https://t.co/Vfnr2u3KDL May 21st 2019, 8:05am |
|
@1MinuteStock Wondering about #sentiment indicator for $DVAX? The Short Ratio is 16.4% https://t.co/C1FO0ImLZV May 21st 2019, 6:05am |
|
@1MinuteStock Not sure what to do with $DVAX? Explore our #fundamental pros and cons. https://t.co/PsFarBIaGV May 21st 2019, 6:05am |
|
@1MinuteStock We calculated 21-day Expected Return of $DVAX for you: -2.86% https://t.co/fbnYIomKvo May 21st 2019, 5:05am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.